131
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Integrating Telemedicine Services in Ophthalmology: Evaluating Patient Interest and Perceived Benefits

, , , , & ORCID Icon
Pages 2335-2341 | Published online: 18 Oct 2021
 

Abstract

Purpose

The purpose of this study was to assess patient interest and willingness to pay (WTP) for teleophthalmology services, whose benefits include improved healthcare access and potential cost savings.

Patients and Methods

Cross-sectional study of 215 patients attending a single tertiary center to assess their interest in teleophthalmology. Comparisons between those interested and those not interested were conducted; logistic regression was used to evaluate the effect of price on interest.

Results

Two thirds (66.5%) of patients were interested in teleophthalmology instead of in-person clinic visits. Those interested were significantly younger than uninterested patients (48.8±22.7 vs 62.4±18.3 years) and were more likely to miss work to attend clinic, own both a computer and smartphone, have experience with video conferencing, and use the internet frequently (all P<0.05). Interested patients were also more likely to indicate time and cost savings, as well as improved follow-up testing, compared to uninterested patients (both P<0.001). Overall, 70.4% of interested patients expressed WTP out-of-pocket for teleservices, especially at low (<$14 US dollars) and moderate-high (>$28) price points. Higher level of education was associated with WTP (OR=2.31, 95% CI 1.05–5.06; P=0.037).

Conclusion

Most patients were interested in teleophthalmology services, especially if they were young, would otherwise miss work, and were familiar with electronics, video conferencing, and internet use. Most interested patients expressed WTP out-of-pocket. Targeting factors related to teleophthalmology interest may increase patient use and enhance communication, thereby improving healthcare access and follow-up.

Acknowledgments

Ms. Zmira Silman is thanked for her assistance with statistical analysis.

Disclosure

Professor Michael Waisbourd reports grants, personal fees from Novartis, outside the submitted work. The author reports no other conflicts of interest in this work.